世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

創薬における人工知能の市場規模、シェア&トレンド分析レポート:アプリケーション別(薬物最適化&再利用、前臨床試験)、治療分野別、地域別、セグメント別予測、2022年~2030年


Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030

創薬における人工知能の市場成長とトレンド Grand View Research, Inc.の新しいレポートによると、創薬における人工知能の世界市場規模は2030年までに91億米ドルに達すると予測されています。2022年から2030年... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年4月11日 US$5,950
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
80 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

創薬における人工知能の市場成長とトレンド

Grand View Research, Inc.の新しいレポートによると、創薬における人工知能の世界市場規模は2030年までに91億米ドルに達すると予測されています。2022年から2030年にかけては、CAGR29.4%で拡大すると予測されています。パンデミックにより、製薬業界ではAIの導入が広まっています。AIとその関連プラットフォームは、医療画像や診断、慢性疾患の管理、薬剤設計の強化を目指している。同じデータをスキャンするAIシステムと比較すると、全体的に人間が費やす時間ははるかに多くなり、全体的なコストを削減し、より実現可能なアプローチとなります。

薬剤最適化および再利用アプリケーションセグメントは、2021年に最大の収益シェアを占めた。AIプラットフォームは、薬物の標的タンパク質の特定に役立ち、薬物が持ちうる有害事象や副作用を判断することができます。薬物分子は、より効果的で副作用を最小限にするために再利用することができます。企業のポートフォリオ薬剤は、新薬開発を早めるために、より速いペースでAIプラットフォームを使用して変更し、研究することができます。

2021年には、腫瘍治療分野セグメントが最大の収益シェアを占めた。製薬会社の大半は、AIスタートアップ企業と提携し、がん研究を最適化しているが、これはまだ未知の領域であり、発見されることは多い。AIシステムは、徹底的に訓練された放射線科医でさえ、通常のスキャンが示すよりもずっと早い段階でがんを特定することができます。その結果、寿命を延ばすことができ、また、がん研究や医薬品開発のために研究すべきマーカーを特定することができます。患者は、自分の遺伝子構成に適した治療法を処方されることができます。

2021年の市場は、北米が支配的だった。現在、多くのテック企業が、製薬会社でのAI活用に向けて資金と労力を投入している。IBMやマイクロソフトなどのテック大手企業は、複数の適応症に対するより迅速な医薬品開発や臨床試験のために、研究機関と協力関係を結んでいる。発展途上国も、薬剤開発や疾病把握のためにAI技術を導入することで、費用対効果の高い方策を見出そうとしています。

創薬における人工知能市場レポートハイライト

- 薬物の最適化と再利用のアプリケーションセグメントが市場を支配し、2021年の収益シェアは50.0%超を占めた

- 治療分野別では、腫瘍分野が20.0%超の収益シェアを占め、2021年に最大となった予測期間中は、感染症セグメントが最も速い成長率を記録すると予想される

- アジア太平洋地域は、2022年から2030年にかけて最も速いCAGR32.2%で拡大すると予想されています。これは、この地域の発展途上国の間で、病気を理解し創薬を支援する手段としてAIの導入が進んでいることに起因している

- 北米は市場をリードし、2021年の収益シェアは55.0%超を占めた。米国は人工知能技術の先駆者であり、この地域の市場成長に大きく寄与しています。

ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Artificial Intelligence in Drug Discovery Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis
3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis
Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.3 Preclinical Testing
4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.4 Other Applications
4.4.1 Other Applications Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.3 Neurodegenerative Diseases
5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.4 Cardiovascular Disease
5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.5 Metabolic Diseases
5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.6 Infectious Disease
5.6.1 Infectious Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
6.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region
6.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2021 & 2030
6.3 North America
6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.3.3 Canada
6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4 Europe
6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.2 U.K.
6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.3 Germany
6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.4 France
6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.5 Spain
6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.6 Italy
6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.7 Russia
6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.2 China
6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.3 India
6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.4 Japan
6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.5 Australia
6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.6 Singapore
6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.7 South Korea
6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6 Latin America
6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.3 Mexico
6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.4 Argentina
6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7 MEA
6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.3 Saudi Arabia
6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.4 UAE
6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators
Chapter 8 Competitive Landscape
8.1 IBM Watson
8.1.1 Company Overview
8.1.2 Finanacial Performance
8.1.3 Offerings
8.1.4 Strategic Initiatives
8.2 Exscientia
8.2.1 Company Overview
8.2.2 Finanacial Performance
8.2.3 Offerings
8.2.4 Strategic Initiatives
8.3 GNS Healthcare
8.3.1 Company Overview
8.3.2 Finanacial Performance
8.3.3 Offerings
8.3.4 Strategic Initiatives
8.4 Alphabet (DeepMind)
8.4.1 Company Overview
8.4.2 Finanacial Performance
8.4.3 Offerings
8.4.4 Strategic Initiatives
8.5 Benevolent AI
8.5.1 Company Overview
8.5.2 Finanacial Performance
8.5.3 Offerings
8.5.4 Strategic Initiatives
8.6 BioSymetrics
8.6.1 Company Overview
8.6.2 Finanacial Performance
8.6.3 Offerings
8.6.4 Strategic Initiatives
8.7 Euretos.
8.7.1 Company Overview
8.7.2 Finanacial Performance
8.7.3 Offerings
8.7.4 Strategic Initiatives
8.8 Berg Health
8.8.1 Company Overview
8.8.2 Finanacial Performance
8.8.3 Offerings
8.8.4 Strategic Initiatives
8.9 Atomwise
8.9.1 Company Overview
8.9.2 Finanacial Performance
8.9.3 Offerings
8.9.4 Strategic Initiatives
8.10 Insitro
8.10.1 Company Overview
8.10.2 Finanacial Performance
8.10.3 Offerings
8.10.4 Strategic Initiatives
8.11 Cyclica
8.11.1 Company Overview
8.11.2 Finanacial Performance
8.11.3 Offerings
8.11.4 Strategic Initiatives

 

ページTOPに戻る


 

Summary

Artificial Intelligence In Drug Discovery Market Growth & Trends

The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 29.4% from 2022 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2021. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2021. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2021. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights

• The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 50.0% in 2021

• By therapeutic area, the oncology segment held the largest revenue share of over 20.0% in 2021. The infectious diseases segment is expected to register the fastest growth rate during the forecast period

• Asia Pacific is expected to expand at the fastest CAGR of 32.2% from 2022 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery

• North America led the market and accounted for a revenue share of over 55.0% in 2021. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Global Artificial Intelligence in Drug Discovery Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Artificial Intelligence in Drug Discovery Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.4 Global Artificial Intelligence in Drug Discovery Market: Pestle Analysis
3.2.5 Global Artificial Intelligence in Drug Discovery Market: Porter’s Analysis
Chapter 4 Global Artificial Intelligence in Drug Discovery Market: Application Estimates & Trend Analysis
4.1 Artificial Intelligence in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.3 Preclinical Testing
4.3.1 Preclinical Testing Market Estimates And Forecasts, 2016 - 2030 (USD Million)
4.4 Other Applications
4.4.1 Other Applications Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 5 Global Artificial Intelligence in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1 Artificial Intelligence in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Oncology Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.3 Neurodegenerative Diseases
5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.4 Cardiovascular Disease
5.4.1 Cardiovascular Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.5 Metabolic Diseases
5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.6 Infectious Disease
5.6.1 Infectious Diseases Market Estimates And Forecasts, 2016 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 6 Global Artificial Intelligence in Drug Discovery Market: Regional Estimates & Trend Analysis
6.1 Global Artificial Intelligence in Drug Discovery Market Movement Ananlysis, By region
6.2 Global Artificial Intelligence in Drug Discovery Market Share, By region, 2021 & 2030
6.3 North America
6.3.1 North America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.3.3 Canada
6.3.3.1 Canada Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4 Europe
6.4.1 Europe Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.2 U.K.
6.4.2.1 U.K. Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.3 Germany
6.4.3.1 Germany Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.4 France
6.4.4.1 France Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.5 Spain
6.4.5.1 Spain Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.6 Italy
6.4.6.1 Italy Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.4.7 Russia
6.4.7.1 Russia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific AI in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.2 China
6.5.2.1 China Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.3 India
6.5.3.1 India Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.4 Japan
6.5.4.1 Japan Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.5 Australia
6.5.5.1 Australia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.6 Singapore
6.5.6.1 Singapore Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.5.7 South Korea
6.5.7.1 South Korea Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6 Latin America
6.6.1 Latin America Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.3 Mexico
6.6.3.1 Mexico Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.6.4 Argentina
6.6.4.1 Argentina Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7 MEA
6.7.1 MEA Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.3 Saudi Arabia
6.6.3.1 Saudi Arabia Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
6.7.4 UAE
6.7.4.1 UAE Artificial Intelligence in Drug Discovery Market Estimates And Forecasts, 2016 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators
Chapter 8 Competitive Landscape
8.1 IBM Watson
8.1.1 Company Overview
8.1.2 Finanacial Performance
8.1.3 Offerings
8.1.4 Strategic Initiatives
8.2 Exscientia
8.2.1 Company Overview
8.2.2 Finanacial Performance
8.2.3 Offerings
8.2.4 Strategic Initiatives
8.3 GNS Healthcare
8.3.1 Company Overview
8.3.2 Finanacial Performance
8.3.3 Offerings
8.3.4 Strategic Initiatives
8.4 Alphabet (DeepMind)
8.4.1 Company Overview
8.4.2 Finanacial Performance
8.4.3 Offerings
8.4.4 Strategic Initiatives
8.5 Benevolent AI
8.5.1 Company Overview
8.5.2 Finanacial Performance
8.5.3 Offerings
8.5.4 Strategic Initiatives
8.6 BioSymetrics
8.6.1 Company Overview
8.6.2 Finanacial Performance
8.6.3 Offerings
8.6.4 Strategic Initiatives
8.7 Euretos.
8.7.1 Company Overview
8.7.2 Finanacial Performance
8.7.3 Offerings
8.7.4 Strategic Initiatives
8.8 Berg Health
8.8.1 Company Overview
8.8.2 Finanacial Performance
8.8.3 Offerings
8.8.4 Strategic Initiatives
8.9 Atomwise
8.9.1 Company Overview
8.9.2 Finanacial Performance
8.9.3 Offerings
8.9.4 Strategic Initiatives
8.10 Insitro
8.10.1 Company Overview
8.10.2 Finanacial Performance
8.10.3 Offerings
8.10.4 Strategic Initiatives
8.11 Cyclica
8.11.1 Company Overview
8.11.2 Finanacial Performance
8.11.3 Offerings
8.11.4 Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(バイオ薬物)の最新刊レポート

本レポートと同じKEY WORD(application drug)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/07 10:27

155.63 円

167.26 円

203.27 円

ページTOPに戻る